31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique - Preliminary findings

Biological Psychiatry

Volumn 41, Issue 6, 1997, Pages 644-648

  Volz, Hans Peter ^a   Rzanny, R ^a   May, S ^a   Hegewald, H ^a   Preussler B ^a   Hajek, M ^a   Kaiser, W A ^a   Sauer, H ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

dorsolateral prefrontal cortex; phosphor magnetic resonance spectroscopy; schizophrenia

Indexed keywords

CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; PHOSPHOLIPID; PHOSPHORUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SPECTROSCOPY; CLINICAL TRIAL; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PSYCHOLOGICAL RATING SCALE;

ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHORUS ISOTOPES; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 0030615082     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00062-5     Document Type: Article

References (16)

1. Andreasen NC, Rezai K, Alliger R, Swayze II VW, Flaum M, Kirchner P, Cohen G, O'Leary DS (1992): Hypofrontality in neuroleptic-naive patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the tower of London. Arch Gen Psychiatry 49:943-958.
2. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biol Psychiatry 32:26-32.
3. Corcoran R, Frith CD (1993): Neuropsychology and neurophysiology in schizophrenia. Curr Opin Psychiatry 6:74-79.
4. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biol Psychiatry 36:503-510.
5. 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand 86:455-462.
6. Gattaz WF, Köllisch M, Thuren T, Virtanen JA, Kinnunen PKJ (1987): Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy. Biol Psychiatry 22:421-426.
7. 2 activity in schizophrenia: A replication study. Biol Psychiatry 28:495-501.
8. Hubesch B, Sappey-Marinier D, Roth K, Meyerhoff DJ, Malson GB, Weiner MW (1990): P-31 MR Spectroscopy of normal human brain and brain tumors. Radiology 174:401-409.
9. 31P-MRS of the frontal lobes in patients with schizophrenia. Proc Soc Magn Res 2:602.
10. Mukherjee S, Mahadik SP (1994): A new paradigm for schizophrenia. Schizophr Res 13:191-194.
11. 31P magnetic resonance spectroscopy. Biol Psychiatry 29:1149-1152.
12. Ordige RJ, Connelly A, Lohman JA (1986): Image-selected in vivo spectroscopy (ISIS). A new technique for spacially selective NMR spectroscopy. J Magn Reson Imaging 66:283-294.
13. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M (1991): Alterations in brain high-energy phosphate and membrane metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 48: 563-568.
14. Shoiri T, Kato T, Inubushi T, Murashita J, Takahashi S (1994): Correlations of phophomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Res 55:223-235.
15. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett RJ, Morrison-Stewart S, Thomson RT (1994): Membrane phospholipid metabolism and schizophrenia: An in vivo 31P-MR spectroscopy study. Schizophr Res 13:209-215.
16. Williamson P, Drost D, Stanley J, Carr T, Morrison S, Merskey H (1991): Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Arch Gen Psychiatry 48:578 (Letter).